DOI:
10.1055/s-00000169
American Journal of Perinatology Reports
LinksClose Window
References
Ariceta G.
Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific way.
Pediatr Nephrol 2019;
34 (05) 943-949
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.